Press Releases

Date	Title and Summary	View
Mar 1, 2022	PerkinElmer to Present at Upcoming Investor Conferences
Feb 23, 2022	TetraScience Announces Collaboration with PerkinElmer to Provide Signals Research™ Suite Customers with Accelerated Time to Value and Improved Scientific Data Outcomes	TetraScience Announces Collaboration with PerkinElmer to Provide Signals Research™ Suite Customers with Accelerated Time to Value and Improved Scientific Data Outcomes
Feb 16, 2022	PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy
Feb 10, 2022	PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
Feb 3, 2022	U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
Feb 1, 2022	PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
Jan 27, 2022	PerkinElmer Board Declares Quarterly Dividend
Jan 11, 2022	PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 1, 2022